Summary
The renal kallikrein-kinin system may participate in the diuretic, natriuretic and antihypertensive effect of diuretics. This possibility was investigated by studying the influence of hydrochlorothiazide on blood pressure and urinary kallikrein excretion in patients with essential hypertension. Furthermore, the effect of kallikrein-blockade and prostaglandin-synthesis inhibition on the acute furosemide-induced changes of diuresis, natriuresis, GFR and renal plasma flow were studied in normotensive subjects. Thiazide treatment normalized the reduced kallikrein excretion of the hypertensive patients. The fall in mean arterial blood pressure was significantly correlated with the increase in urinary kallikrein excretion. In the normotensive subjects aprotinin-induced kallikrein inhibition failed to alter the acute response to furosemide, whereas indomethacin attenuated the diuretic and natriuretic effect of furosemide. The combination of indomethacin and aprotinin had a greater suppressive effect on plasma renin activity than indomethacin alone, suggesting a participation of kallikrein in renin release. An increase in the activity of the renal kallikreinkinin system may contribute to the long-term antihypertensive effect of thiazide diuretics but it does not seem to be involved in the acute renal responses to furosemide.
Zusammenfassung
Das renale Kallikrein-Kinin System ist möglicherweise am diuretischen, natriuretischen und antihypertensiven Effekt von Diuretika beteiligt. In der vorliegenden Studie wurde deshalb an Patienten mit essentieller Hypertension der Einfluß von Hydrochlorothiazid auf das Blutdruckverhalten und die renale Kallikreinaktivität untersucht. Zusätzlich wurde bei Normalpersonen die Beeinflußbarkeit der renalen Furosemidwirkung durch Kallikreinblockade und Hemmung der Prostaglandinsynthese gemessen.
Hydrochlorothiazidbehandlung normalisierte die erniedrigte Kallikreinausscheidung hypertensiver Patienten. Der Abfall des mittleren arteriellen Drucks korrelierte mit dem Anstieg der Kallikreinausscheidung. Bei den normotensiven Probanden wurden die akuten Furosemid-induzierten Änderungen von Diurese, Natriurese, glomerulärer Filtration und renalem Plasmafluß durch Kallikreinhemmung mit Aprotinin nicht beeinflußt. Indomethacin hingegen verminderte den diuretischen und natriuretischen Effekt von Furosemid. Die Plasmareninaktivität wurde durch die Kombination von Indomethacin und Aprotinin deutlicher supprimiert als durch Indomethacin allein. Dies könnte auf eine Beteiligung von Kallikrein an der Reninfreisetzung hinweisen. Eine Aktivitätszunahme des renalen Kallikrein-Kinin Systems könnte zum antihypertensiven Effekt der Thiaziddiuretika beitragen. Andererseits scheint dieses System an den akuten renalen Wirkungen von Furosemid nicht beteiligt zu sein.
Similar content being viewed by others
References
Amundsen E, Pütter J, Friberger P, Knos M, Larsbraten M, Claeson G (1979) Methods for the determination of glandular kallikrein by means of a chromogenic substrate. In: Kinins II, Biochemistry, Pathophysiology and Clinical Aspects (ed by Fujii S, Moriya H, Suzuki T) Plenum Press, New York, pp 359–367
Bailie MD, Barbour JA, Hook JB (1975) Effects of indomethacin on furosemide-induced changes in renal blood flow. Proc Soc Exp Biol Med 148:1173–1176
Barraclough MA, Mills JH (1965) Effect of Bradykinin on renal function. Clin Sci 28:69–74
Birbari A, Dagher G (1977) Role of prostaglandin E in the diuretic action of furosemide. Kidney Int 12:551–556
Carretero OA, Scicli AG (1980) The renal kallikrein-kinin system. Am J Physiol 238:247–255
Carretero OA, Scicli AG (1981) Possible role of kinins in circulatory homeostasis. Hypertension 3:I-4 – I-12
Chiu PJS, Long JF (1981) Effects of prostaglandin and kinin synthesis inhibitors on renal responses to furosemide in normal and low-sodium rats. Arch Int Pharmacodyn 249:297–305
Croxatto HR, Roblero RJ, Garcia R, Corthorn J, San Martin ML (1973) Effect of furosemide upon urinary kallikrein excretion. Agents and Actions 3:267–274
Derkx FHM, Bouma BN, Schalekamp MPA, Schalekamp MADH (1979) An intrinsic factor XII-prekallikrein-dependent pathway activates the human plasma renin-angiotensin system. Nature 280:315–316
Dray F, Charbonnel B, Maclouf J (1975) Radioimmunoassay of prostaglandin F, E1 and E2 in human plasma. Europ J Clin Invest 5:311–318
Flower RJ (1974) Drugs which inhibit prostaglandin biosynthesis. Pharmacological Reviews 26:33–67
Frölich JC, Hollifield JW, Dormois JC, Frölich BL, Seyberth H, Michelakis AM, Oates JA (1976) Suppression of plasma renin activity by indomethacin in man. Circ Res 39:447–452
Haber E, Koerner T, Page LB, Kliman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29:1349–1355
Kramer HJ, Düsing R, Stinnesbeck B, Prior W, Bäcker A, Eden J, Kipnowski J, Glänzer K, KrÜck F (1980) Interaction of conventional and antikaliuretic diuretics with the renal prostaglandin system. Clin Sci 59:67–70
Lechi A, Covi G, Lechi C, Corgnati A, Arosio E, Zatti M, Scuro LA (1978) Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism. Clin Sci Mol Med 55:51–55
Margolius HS, Geller R, Pisano JJ, Sjoerdsma A (1971) Altered urinary kallikrein excretion in human hypertension. Lancet, 1063–1065
Margolius HS, Horwitz D, Pisano JJ, Keiser HR (1974) Urinary kallikrein excretion in hypertensive man. Circ Res 35:820–825
Nielsen CK, Arrigoni-Martelli E (1976) Effects on rat urinary kallikrein excretion of bumetanide, bendroflumethiazide and hydralazine. Acta Pharmacol Toxicol 40:267–272
Nustad K, Vaaje K, Pierce JV (1975) Synthesis of kallikreins by rat kidney slices. Br J Pharmac 53:229–234
O'Connor DT, Preston RA, Mitas JA, Frigon RP, Stone RA (1981) Urinary kallikrein activity and renal vascular resistance in the antihypertensive response to thiazide diuretics. Hypertension 3:139–147
Olsen UB, Ahrfelt-Rønne J (1975) Bumetanide induced increase of renal blood flow in conscious dogs and its relation to local renal hormones. (PGE, kallikrein and renin). Acta Pharmacol Toxicol 38:219–228
Olshan AR, O'Connor DT, Preston RA, Frigon RP, Stone RA (1981) Involvement of kallikrein in the antihypertensive response to furosemide in essential hypertension. J Cardiovasc Pharmacol 3:161–167
Overlack A, Stumpe KO, Ressel C, Kolloch R, Zywzok W, Krück F (1980) Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension. Klin Wochenschr 58:37–42
Patak RV, Mookerjee BK, Bentzel CJ, Hysert PE, Babey M, Lee JB (1975) Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins 10:649–659
Patak RV, Fadem SZ, Rosenblatt SG, Lifschitz MD, Stein JH (1979) Diuretic-induced changes in renal blood flow and prostaglandin E excretion in the dog. Am J Physiol 236:494–500
Rumpf KW, Frenzel S, Lowitz HD, Scheler F (1976) Die Wirkung von Indomethacin auf die basale und stimulierte Plasmareninaktivität beim Menschen. Klin Wochenschr 54:255–259
Scicli AG, Carretero GA, Hampton A, Cortes P, Oza NB (1976) Site of kininogenase secretion in the dog nephron. Am J Physiol 230:533–536
Sealey JE, Atlas SA, Laragh JH, Oza NB, Ryan JW (1978) Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin. Nature 275:144–145
Sealey JE, Overlack A, Laragh JH, Stumpe KO, Atlas SA (1981) Effect of captopril and aprotinin on inactive renin. J Clin Endocrinol Metab 53:626–630
Seino M, Abe K, Otsuka Y, Saito T, Orokawa N, Yasujima M, Chiba S, Yoshinaga K (1975) Urinary kallikrein excretion and sodium metabolism in hypertensive patients. Tohoku J Exp Med 116:359–367
Seino M, Abe K, Irokawa N, Ito T, Yasujima M, Sakurai Y, Chiba S, Saito K, Ritz K, Kusaka T, Miyazaki S, Yoshinaga K (1978) Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension. Tohoku J Exp Med 124:197–203
Seldin DW, Eknogan G, Suki N, Rector jr FC (1966) Localization of diuretic action from the pattern of water and electrolyte excretion. Ann Y Acad Sci 139:328–345
Smith HW, Goldring W, Chasis H (1938) The measurement of the tubular excretory mass, effective blood flow and filtration rate in the normal human kidney. J Clin Invest 17:263–275
Suzuki S, Franco-Saenz R, Tan SY, Mulrow PJ (1980) Direct action of rat urinary kallikrein on rat kidney to release renin. J Clin Invest 66:757–762
Vetter W, Vetter H, Siegenthaler W (1973) Radioimmunoassay for aldosterone without chromatography. 2. Determination of plasma aldosterone. Acta Endocrinol 74:558–564
Vogel R, Werle E (1970) Kallikrein inhibitors. In: Bradykinin, kallidin and kallikrein. Handb Exp Pharmacol (ed by Erdös EG) Springer, New York, pp 213–249
Weber PC, Siess W, Scherer B (1979) Vaskuläre, thrombozytäre und renale Prostaglandine. Klin Wochenschr 57:425–444
Webster ME, Gilmore JP (1964) Influence of kallidin-10 on renal function. Am J Physiol 206:714–718
Williamson HE, Bourland WA, Marchand GR (1975) Inhibition of furosemide induced increase in renal blood flow by indomethacin. Proc Soc Exp Biol Med 148:164–167
Willis LR, Ludens JH, Hook JB, Williamson HE (1969) Mechanism of natriuretic action of bradykinin. Am J Physiol 217:1–5
Author information
Authors and Affiliations
Additional information
Dedicated to Professor F. Krück on the occasion of his 60th birthday
Supported in part by the Ministerium für Wissenschaft und Forschung, Nordrhein-Westfalen (Grant No. IV B5-FA 8421)
Rights and permissions
About this article
Cite this article
Overlack, A., Stumpe, K.O., Müller, H.M. et al. Interactions of diuretics with the renal kallikrein-kinin and prostaglandin systems. Klin Wochenschr 60, 1223–1228 (1982). https://doi.org/10.1007/BF01716727
Issue Date:
DOI: https://doi.org/10.1007/BF01716727
Key words
- Renal kallikrein-kinin system
- Renal prostaglandins
- Action of diuretics
- Renin release
- Essential hypertension